Minimizing therapeutically induced anemia.
A model for erythroid production based on a continuous maturation-proliferation scheme is developed. The model includes a simple control mechanism operating at the proliferating cell level, and analytic solutions for the time dependent response of the model are derived. Using this model, the response of the erythron to a massive depletion of the proliferating cell compartment (due for example to cytostatic drugs or radiation) is calculated. It is demonstrated that a therapeutic measure designed to decrease the erythroid precursor maturation velocity may considerably ameliorated the deleterious effects of proliferating cell destruction. One way to decrease the erythroid cell maturation rate would be by having the patient breathe in an oxygen enriched atmosphere.
D000740:Anemia / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects; D002455:Cell Division / Q000187:drug effects; D004912:Erythrocytes / Q000187:drug effects* / Q000473:pathology; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008954:Models, Biological; D010102:Oxygen Inhalation Therapy
D000970:Antineoplastic Agents